Similar to the US, Canada has a patent linkage system that requires generics to address certain patents before obtaining regulatory approval of drugs. Although in theory the two systems are similar, in practice there are nuances that make them different. Published in LMG Life Sciences, 2, pp. 153-154.
Article
The Same But Different: Patent Linkage in Canada
January 1, 2013
Republishing Requests
For permission to republish this or any other publication, contact Amrita Kochhar at kochhara@bennettjones.com.
For informational purposes only
This publication provides an overview of legal trends and updates for informational purposes only. For personalized legal advice, please contact the authors.
From the Same Authors
See AllLatest Insights
See All InsightsBlog